IM Cannabis Corp. (IMCC)
NASDAQ: IMCC · Real-Time Price · USD
1.990
+0.030 (1.53%)
Sep 9, 2026, 4:00 PM EDT - Market closed
IM Cannabis Employees
IM Cannabis had 44 employees as of December 31, 2025. The number of employees decreased by 51 or -53.68% compared to the previous year.
Employees
44
Change
-51
Growth
-53.68%
Revenue / Employee
$733,031
Profits / Employee
-$286,840
Market Cap
1.23M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 44 | - | - |
| Dec 31, 2023 | 95 | - | - |
| Dec 31, 2021 | 283 | - | - |
| Jun 30, 2019 | 8 | - | - |
| Mar 31, 2019 | 8 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| China SXT Pharmaceuticals | 56 |
| Sunshine Biopharma | 50 |
| cbdMD | 42 |
| BioXcel Therapeutics | 29 |
| RedHill Biopharma | 13 |
| InMed Pharmaceuticals | 13 |
| Sonoma Pharmaceuticals | 10 |
| PRF Technologies | 7 |
IMCC News
- 7 days ago - IM Cannabis Raises US$225,000 of Gross Proceeds in Convertible Note Financing - PRNewsWire
- 13 days ago - IM Cannabis Shares Commence Trading on 30:1 Consolidated Basis - PRNewsWire
- 14 days ago - IM Cannabis trading halted, news pending - TheFly
- 22 days ago - IM Cannabis Announces Intention to Complete 30:1 Share Consolidation to Support Nasdaq Minimum Bid Price Compliance - PRNewsWire
- 23 days ago - IM Cannabis Enters into Agreement to Sell IMC Holdings and European- Focused Assets - PRNewsWire
- 27 days ago - IM Cannabis Corp. Announces Second Quarter and First Half 2026 Financial Results - PRNewsWire
- 27 days ago - IM Cannabis Earnings release: Q2 2026 - Filings
- 4 weeks ago - IM Cannabis Raises US$250,000 of Gross Proceeds in Convertible Note Financing - PRNewsWire